CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated deficit	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Balance (in shares) at Dec. 31, 2021		20,261
Balance at beginning of period at Dec. 31, 2021	$ 133,716	$ 217	$ 454,852	$ (198,081)	$ (48,800)	$ (74,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(21,481)			(21,481)
Other comprehensive income (loss), net of tax	(1,331)				(1,331)
Conversion of restricted stock units (shares)		50
Conversion of restricted stock units	(499)		(499)
Share-based plan compensation	(84)		(84)
Balance (in shares) at Apr. 03, 2022		20,311
Balance at end of period at Apr. 03, 2022	110,321	$ 217	454,269	(219,562)	(50,131)	(74,472)
Balance (in shares) at Dec. 31, 2021		20,261
Balance at beginning of period at Dec. 31, 2021	133,716	$ 217	454,852	(198,081)	(48,800)	(74,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(17,521)
Other comprehensive income (loss), net of tax	(12,041)
Balance (in shares) at Jul. 03, 2022		20,352
Balance at end of period at Jul. 03, 2022	103,663	$ 217	454,361	(215,602)	(60,841)	(74,472)
Balance (in shares) at Apr. 03, 2022		20,311
Balance at beginning of period at Apr. 03, 2022	110,321	$ 217	454,269	(219,562)	(50,131)	(74,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	3,960			3,960
Other comprehensive income (loss), net of tax	(10,710)				(10,710)
Conversion of restricted stock units (shares)		41
Conversion of restricted stock units	(367)	$ 0	(367)
Share-based plan compensation	459		459
Balance (in shares) at Jul. 03, 2022		20,352
Balance at end of period at Jul. 03, 2022	103,663	$ 217	454,361	(215,602)	(60,841)	(74,472)
Balance (in shares) at Dec. 31, 2022		20,364
Balance at beginning of period at Dec. 31, 2022	159,046	$ 218	456,102	(178,693)	(44,109)	(74,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(407)			(407)
Other comprehensive income (loss), net of tax	2,016				2,016
Conversion of restricted stock units (shares)		26
Conversion of restricted stock units	(450)		(450)
Share-based plan compensation	1,033		1,033
Balance (in shares) at Apr. 02, 2023		20,390
Balance at end of period at Apr. 02, 2023	161,238	$ 218	456,685	(179,100)	(42,093)	(74,472)
Balance (in shares) at Dec. 31, 2022		20,364
Balance at beginning of period at Dec. 31, 2022	159,046	$ 218	456,102	(178,693)	(44,109)	(74,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(8,978)
Other comprehensive income (loss), net of tax	1,130
Balance (in shares) at Jul. 02, 2023		20,392
Balance at end of period at Jul. 02, 2023	153,048	$ 218	457,952	(187,671)	(42,979)	(74,472)
Balance (in shares) at Apr. 02, 2023		20,390
Balance at beginning of period at Apr. 02, 2023	161,238	$ 218	456,685	(179,100)	(42,093)	(74,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(8,571)			(8,571)
Other comprehensive income (loss), net of tax	(886)				(886)
Conversion of restricted stock units (shares)		2
Conversion of restricted stock units	(23)		(23)
Share-based plan compensation	1,290		1,290
Balance (in shares) at Jul. 02, 2023		20,392
Balance at end of period at Jul. 02, 2023	$ 153,048	$ 218	$ 457,952	$ (187,671)	$ (42,979)	$ (74,472)